Cargando…

Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India

Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspe...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Dayoung, Pallas, Sarah W., Shimpi, Rahul, Ramaswamy, N., Haldar, Pradeep, Harvey, Pauline, Bhatnagar, Pankaj, Katkar, Arun, Jayaprasad, Niniya, Kunwar, Abhishek, Bahl, Sunil, Morgan, Win, Hutubessy, Raymond, Date, Kashmira, Mogasale, Vittal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/
https://www.ncbi.nlm.nih.gov/pubmed/36962873
http://dx.doi.org/10.1371/journal.pgph.0001396
_version_ 1784908713080913920
author Song, Dayoung
Pallas, Sarah W.
Shimpi, Rahul
Ramaswamy, N.
Haldar, Pradeep
Harvey, Pauline
Bhatnagar, Pankaj
Katkar, Arun
Jayaprasad, Niniya
Kunwar, Abhishek
Bahl, Sunil
Morgan, Win
Hutubessy, Raymond
Date, Kashmira
Mogasale, Vittal
author_facet Song, Dayoung
Pallas, Sarah W.
Shimpi, Rahul
Ramaswamy, N.
Haldar, Pradeep
Harvey, Pauline
Bhatnagar, Pankaj
Katkar, Arun
Jayaprasad, Niniya
Kunwar, Abhishek
Bahl, Sunil
Morgan, Win
Hutubessy, Raymond
Date, Kashmira
Mogasale, Vittal
author_sort Song, Dayoung
collection PubMed
description Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning.
format Online
Article
Text
id pubmed-10022355
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100223552023-03-17 Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India Song, Dayoung Pallas, Sarah W. Shimpi, Rahul Ramaswamy, N. Haldar, Pradeep Harvey, Pauline Bhatnagar, Pankaj Katkar, Arun Jayaprasad, Niniya Kunwar, Abhishek Bahl, Sunil Morgan, Win Hutubessy, Raymond Date, Kashmira Mogasale, Vittal PLOS Glob Public Health Research Article Navi Mumbai Municipal Corporation (NMMC), a local government in Mumbai, India, implemented the first public sector TCV campaign in 2018. This study estimated the delivery costs of this TCV campaign using a Microsoft Excel-based tool based on a micro-costing approach from the government (NMMC) perspective. The campaign’s financial (direct expenditures) and economic costs (financial costs plus the monetized value of additional donated or existing items) incremental to the existing immunization program were collected. The data collection methods involved consultations with NMMC staff, reviews of financial and programmatic records of NMMC and the World Health Organization (WHO), and interviews with the health staff of sampled urban health posts (UHPs). Three UHPs were purposively sampled, representing the three dominant residence types in the catchment area: high-rise, slum, and mixed (high-rise and slum) areas. The high-rise area UHP had lower vaccination coverage (47%) compared with the mixed area (71%) and slum area UHPs (76%). The financial cost of vaccine and vaccination supplies (syringes, safety boxes) was $1.87 per dose, and the economic cost was $2.96 per dose in 2018 US dollars. Excluding the vaccine and vaccination supplies cost, the financial delivery cost across the 3 UHPs ranged from $0.37 to $0.53 per dose, and the economic delivery cost ranged from $1.37 to $3.98 per dose, with the highest delivery costs per dose in the high-rise areas. Across all 11 UHPs included in the campaign, the weighted average financial delivery cost was $0.38 per dose, and the economic delivery cost was $1.49 per dose. WHO has recommended the programmatic use of TCV in typhoid-endemic countries, and Gavi has included TCV in its vaccine portfolio. This first costing study of large-scale TCV introduction within a public sector immunization program provides empirical evidence for policymakers, stakeholders, and future vaccine campaign planning. Public Library of Science 2023-01-04 /pmc/articles/PMC10022355/ /pubmed/36962873 http://dx.doi.org/10.1371/journal.pgph.0001396 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Song, Dayoung
Pallas, Sarah W.
Shimpi, Rahul
Ramaswamy, N.
Haldar, Pradeep
Harvey, Pauline
Bhatnagar, Pankaj
Katkar, Arun
Jayaprasad, Niniya
Kunwar, Abhishek
Bahl, Sunil
Morgan, Win
Hutubessy, Raymond
Date, Kashmira
Mogasale, Vittal
Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_full Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_fullStr Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_full_unstemmed Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_short Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India
title_sort delivery cost of the first public sector introduction of typhoid conjugate vaccine in navi mumbai, india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022355/
https://www.ncbi.nlm.nih.gov/pubmed/36962873
http://dx.doi.org/10.1371/journal.pgph.0001396
work_keys_str_mv AT songdayoung deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT pallassarahw deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT shimpirahul deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT ramaswamyn deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT haldarpradeep deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT harveypauline deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT bhatnagarpankaj deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT katkararun deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT jayaprasadniniya deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT kunwarabhishek deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT bahlsunil deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT morganwin deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT hutubessyraymond deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT datekashmira deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia
AT mogasalevittal deliverycostofthefirstpublicsectorintroductionoftyphoidconjugatevaccineinnavimumbaiindia